About
Innovative Urine Liquid Biopsy Solutions Transforming Cancer Care
At UGenDX Ltd, we are dedicated to revolutionizing non-invasive cancer diagnostics through cutting-edge,urine liquid biopsy technology. Our mission is to empower clinicians with next generation diagnostic tools to improve patient diagnostic outcomes and foster more effective treatment strategies.
Advancing Cancer Detection Through Urine Liquid Biopsy
Meet the dedicated experts driving innovation at UGenDX Ltd.
Sushant Dhanvijay
Founder/ CEO
Sushant leads Ugendx with more than 18 years of expertise in cancer diagnostics, manufacturing, and regulatory affairs. He is also the inventor of the Urodyne technology.
Kami Kundi
Chief Business Manager
Kami brings experience in helping start-ups with grants and funding and oversee business managment at Ugendx.
Dr Andrew Ball
Scientific Lead
Dr. Ball holds a PhD in Biochemistry from UCL and has a broad background in molecular biology, assay development, and microscopy. He played a key role in developing the predicate device behind UroDyne.
Sanjay Ingle
Chief Asia Technical Officer
Dr. Sanjay heads operations at Apollo Health & Lifestyle, Pune, overseeing 21 labs across the West Zone. A former chief at Dr. Lal PathLabs, he is an ISO 15189-certified lead and technical assessor, and a recognized authority in pathology
Kasra Saeb-Parsy
Chief Medical Officer
Consultant Urologist
Internationally recognized Consultant Urologist at Cambridge University Hospitals and Honorary Senior Lecturer at Anglia Ruskin University, bringing over 25 years of clinical expertise in advanced urological medicine.
Natasha Gedamker
Operations Manager
Natasha oversees all operations at Ugendx. She coordinates with teams to meet the company’s strategic goals.
Deepali Mishra
Regulatory Lead
Deepali is a Regulatory Affairs Specialist with 10+ years of experience in MedTech and pharma, skilled in global compliance (EU-MDR, FDA, UK MDR), ISO 13485 QMS, and technical documentation.
Innovating Non-Invasive Cancer Detection
Hear from clinicians who trust our cutting-edge urine liquid biopsy technology to improve diagnostic outcome.
UGenDX’s diagnostic tools have transformed how we approach cancer detection, delivering precise and timely insights.
Dr. Emily Harris
Oncologist at Riverside Medical Center
The team’s expertise and dedication made a significant difference in our diagnostic capabilities.
Dr. Michael Lee
Pathology Specialist, City Health Clinic
UGenDX provides reliable, high-quality diagnostics that have enhanced our treatment planning significantly.
Dr. Sophia Patel
Clinical Researcher, Metro Cancer Institute
The accuracy and ease of their non-invasive tests have improved patient outcomes profoundly.
Dr. James Carter
Lead Scientist, Horizon Diagnostics